Federica Mazzuca | Ricerc@Sapienza

Pubblicazioni

Titolo	Pubblicato in	Anno
CYP19A1 Genetic Polymorphisms rs4646 and Osteoporosis in Patients Treated with Aromatase Inhibitor-Based Adjuvant Therapy	THE EURASIAN JOURNAL OF MEDICINE	2016
The TYMS-TSER polymorphism is associated with toxicity of low-dose capecitabine in patients with advanced gastrointestinal cancer	ANTI-CANCER DRUGS	2016
Pre-treatment assay of 5-fluorouracil degradation rate (5-FUDR) to improve prediction of 5-fluorouracil toxicity in gastro-esophageal cancer	ONCOTARGET	2016
Degradation rate of 5-fluorouracil in metastatic colorectal cancer. A new predictive outcome biomarker?	PLOS ONE	2016
5-Fluorouracil degradation rate could predict toxicity in stages II-III colorectal cancer patients undergoing adjuvant FOLFOX	ANTI-CANCER DRUGS	2016
F295-fluorouracil degradation rate (5-FU-DR) could predict toxicity in breast cancer patients treated with capecitabine	ANNALS OF ONCOLOGY	2016
Genotype–phenotype correlations in 5-fluorouracil metabolism. a candidate DPYD haplotype to improve toxicity prediction	PHARMACOGENOMICS JOURNAL	2015
Effect of MTHFR polymorphisms on gastrointestinal cancer risk in Italy	WORLD JOURNAL OF ONCOLOGY	2015
Electrochemotherapy treatment of cutaneous metastases from breast cancer	THE AMERICAN SURGEON	2015
Positive impact of elastography in breast cancer diagnosis: an institutional experience	JOURNAL OF ULTRASOUND	2015
FCGRs Polymorphisms and Response to Trastuzumab in Patients With HER2-Positive Breast Cancer: Far From Predictive Value?	WORLD JOURNAL OF ONCOLOGY	2015